Skip to main content

Table 1 Clinical and biochemical characteristics of metabolically healthy non-obese (MHNO), metabolically healthy obese (MHO) and metabolically abnormal diabetic obese (MADO) subjects

From: Favourable metabolic profile sustains mitophagy and prevents metabolic abnormalities in metabolically healthy obese individuals

Variables

MHNO (n = 20)

MHO (n = 20)

MADO (n = 20)

Age (years)

38.9 ± 7.2

41.5 ± 6.5

43.7 ± 10.8*

Gender (M:F)

12:8

11:9

11: 9

Wt (kg)

63.8 ± 7.7

72.2 ± 8.3*

73.1 ± 10.5*

BMI (kg/m2)

21.2 ± 1.6

28.5 ± 2.4***

29.4 ± 3.5***

WC (cm)

81.0 ± 5.2

96.3 ± 7.7***

98.6 ± 8.0***

Body Fat (%)

22.8 ± 6.2

33.6 ± 7.4*

35.0 ± 10.4***

Systolic BP (mm/Hg)

119.7 ± 12.1

122.7 ± 10.7

126.2 ± 15.2

Diastolic BP (mm/Hg)

80.7 ± 7.9

85.0 ± 6.1

81.8 ± 9.6

FPG (mmol/l)

5.1 ± 0.4

5.2 ± 0.7

8.6 ± 1.4***###

2hPG (mmol/l)

5.6 ± 1.3

6.8 ± 1.2

13.6 ± 2.7***###

HbA1C (%)

5.2 ± 0.2

5.3 ± 0.4

7.7 ± 0.5***###

FPI (μIU/ml)

9.7 ± 6.2

11.9 ± 5.1

13.6 ± 4.7

HOMA-IR

2.2 ± 1.4

2.4 ± 1.0

5.4 ± 2.5***###

HOMA-β %

119.5 ± 83.6

156.3 ± 81.1

54.2 ± 17.6***###

S. CHOL (mg/dl)

185.2 ± 39.1

180.4 ± 37.5

206.9 ± 44.8

S. LDL-C (mg/dl)

112.5 ± 27.9

108.1 ± 32.2

141.0 ± 36.7*##

S. TG (mg/dl)

134.2 ± 77.8

140.4 ± 70.2

152.2 ± 57.3

S. HDL-C (mg/dl)

44.2 ± 7.7

50.1 ± 16.7

44.2 ± 6.7

IL-6 (pg/ml)

6.9 ± 1.1

8.2 ± 2.2

15.2 ± 2.6**#

hsCRP (mg/dl)

0.7 ± 0.4

1.7 ± 1.2*

3.8 ± 2.3***#

  1. Data expressed as mean ± SD, * p < 0.05, ** p < 0.01, *** p < 0.001 vs. MHNO
  2. #p < 0.05, ## p < 0.01, ### p < 0.001 vs. MHO